Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
, and improve agent efficiency. Contributes to the development and maintenance of knowledge articles, job aids, and training content based on recurring Tier 2 issues. Reporting & Continuous Improvement
-
areas of the brain. Treatment is based on rapid delivery of the thrombolytic agent (t-PA), but the delivery of the drug is limited by the obstruction of the vessels. In this project, the post-doctoral
-
based on training and experience. This position will perform research on toxicological evaluation of aerosolized environmental agents to understand cellular interactions and exposure risk. This position
-
position within a Research Infrastructure? No Offer Description Laboratory of Molecular and Cellular Neurobiology https://shorturl.at/mLd8y at the International Institute for Molecular and Cell Biology
-
, systems, and hardware design. Experience in one or more of: LLMs, AI agents, embedded ML, physical modelling and simulation Strong programming skills in Python and C/C++, familiarity with ML deployment
-
. Candidates will perform research on agentic AI, foundational modeling, optimization, and control of multiagent autonomous systems with an application in renewable energy and power grids, in addition to working
-
Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S) | Portugal | about 1 month ago
microenvironment, and improves CAR-T cell efficacy in preclinical models. The SPECIFIC AIMS of this project are: 1) to determine the impact of PSGL-1 blockade on the immunophenotype and transcriptional programs
-
platform – creation of a domain-specific, constrained Large Language Model (LLM) and AI agents for use within an OMS; Model development and training; Integration of AI agents. Applicable legislation and
-
fungal infections. Emerging research is exploring radiometals conjugated with targeting molecules for in vivo imaging of infections via PET or SPECT. These agents can also be linked to therapeutics
-
applications. This project key innovation lies in incorporating novel antivirulence compounds (agents that target bacterial quorum sensing rather than viability) into these scaffolds. By inhibiting pathogenic